

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1251 daily bars · split adjusted
Current price $28.02
Latest analyst grade actions
Daily · Wilder smoothing
Classic floor pivots from 2026-10-20
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 78.50 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 50.00 | Oscillator | Neutral |
| Williams %R (14) | -50.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.02 (Hist -0.01) | Oscillator | Sell |
| Average Directional Index (14) | NaN (+DI 78.5 / -DI 21.5) | Trend | Buy |
| EMA 20 | 28.02 | MA | Buy |
| SMA 20 | 28.02 | MA | Buy |
| EMA 50 | 27.88 | MA | Buy |
| SMA 50 | 28.02 | MA | Sell |
| SMA 200 | 26.54 | MA | Strong Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 22, 2026 | 0.49 | 0.50 | Beat 3.8% | $226.3M |
| Jul 15, 2026 | 0.48 | 0.49 | Beat 2.2% | $251.2M |
| Apr 24, 2026 | 0.43 | 0.43 | Miss -0.6% | $251.0M |
| Feb 18, 2026 | 0.45 | 0.52 | Beat 15.2% | $266.8M |
| Oct 23, 2025 | 0.50 | 0.49 | Miss -2.3% | $256.4M |
| Jul 15, 2025 | 0.47 | 0.47 | Miss -0.9% | $247.7M |
TTM vs. 5-year historical average (annual ratios)
| Metric | CWQXY | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 22.5x | 23.3x · sector 36.8x | Discount |
| Forward P/E (FY26E) | 1.6x | EPS est. 17.08 | Discount |
| Price / Book | 0.9x | 0.7x | Elevated |
| Price / Sales | 6.1x | 6.5x | In line |
| EV / EBITDA | 25.8x | 19.2x | Elevated |
| Return on equity | 3.9% | — | Weak |
| Gross margin | 68.4% | 74.3% | In line |
| Debt / Equity | 1.05 | 0.89 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 0.79 | Distress |
Discounted cash flow model